 Dasatinib

Dasatinib, sold under the brand name Sprycel among others, is a targeted therapy used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).Specifically it is used to treat cases that are Philadelphia chromosome-positive (Ph+).